MA50141A - Procédés de purification de protéines de fusion d'albumine - Google Patents

Procédés de purification de protéines de fusion d'albumine

Info

Publication number
MA50141A
MA50141A MA050141A MA50141A MA50141A MA 50141 A MA50141 A MA 50141A MA 050141 A MA050141 A MA 050141A MA 50141 A MA50141 A MA 50141A MA 50141 A MA50141 A MA 50141A
Authority
MA
Morocco
Prior art keywords
fusion protein
protein purification
albumin fusion
purification processes
processes
Prior art date
Application number
MA050141A
Other languages
English (en)
Inventor
Are Bogsnes
Viveka Dolby
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of MA50141A publication Critical patent/MA50141A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
    • B01D15/16—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to the conditioning of the fluid carrier
    • B01D15/166—Fluid composition conditioning, e.g. gradient
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • B01D15/361—Ion-exchange
    • B01D15/362—Cation-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/42—Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
    • B01D15/424—Elution mode
    • B01D15/426—Specific type of solvent
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/31—Fusion polypeptide fusions, other than Fc, for prolonged plasma life, e.g. albumin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
MA050141A 2017-04-20 2018-04-19 Procédés de purification de protéines de fusion d'albumine MA50141A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP17167261 2017-04-20

Publications (1)

Publication Number Publication Date
MA50141A true MA50141A (fr) 2020-07-29

Family

ID=58632195

Family Applications (1)

Application Number Title Priority Date Filing Date
MA050141A MA50141A (fr) 2017-04-20 2018-04-19 Procédés de purification de protéines de fusion d'albumine

Country Status (6)

Country Link
US (2) US20200131225A1 (fr)
EP (1) EP3612558A1 (fr)
JP (1) JP2020517657A (fr)
CN (1) CN110770251A (fr)
MA (1) MA50141A (fr)
WO (1) WO2018193033A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10588980B2 (en) 2014-06-23 2020-03-17 Novartis Ag Fatty acids and their use in conjugation to biomolecules
CN113880908B (zh) * 2021-08-25 2024-05-14 北京伟德杰生物科技有限公司 纯化重组人血清白蛋白的融合蛋白的方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2686899B1 (fr) * 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
GB9526733D0 (en) * 1995-12-30 1996-02-28 Delta Biotechnology Ltd Fusion proteins
GB9902000D0 (en) * 1999-01-30 1999-03-17 Delta Biotechnology Ltd Process
US6926898B2 (en) 2000-04-12 2005-08-09 Human Genome Sciences, Inc. Albumin fusion proteins
EP1463752A4 (fr) 2001-12-21 2005-07-13 Human Genome Sciences Inc Proteines de fusion d'albumine
KR101271635B1 (ko) * 2001-12-21 2013-06-12 휴먼 게놈 사이언시즈, 인코포레이티드 알부민 융합 단백질
CN101172091B (zh) 2007-09-25 2011-04-27 北京美福源生物医药科技有限公司 含人血清白蛋白与皮肤细胞生长因子的融合蛋白护肤产品制备工艺和用途
EP1444986A1 (fr) * 2003-02-07 2004-08-11 Aventis Behring GmbH Preparation pharmaceutique pour l'amélioration du traitement des maladies liées à une coagulation sanguine diminuée
GB0305989D0 (en) * 2003-03-15 2003-04-23 Delta Biotechnology Ltd Agent
WO2005047334A1 (fr) * 2003-11-13 2005-05-26 Hanmi Pharmaceutical. Co., Ltd. Fragment d'igg fc pour vecteur de medicament et procede de preparation associe
JP2009504157A (ja) * 2005-08-12 2009-02-05 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド アルブミン融合タンパク質
DK2427486T3 (en) * 2009-05-07 2015-05-26 Novozymes Biopharma Dk As A process for purifying albumin
EP3157947A1 (fr) 2014-06-23 2017-04-26 Novartis AG Polypeptide de fusion hsa-gdf-15 et son utilisation
US9272019B2 (en) * 2014-06-24 2016-03-01 Novo Nordisk A/S MIC-1 fusion proteins and uses thereof
SG11201700378PA (en) * 2014-07-30 2017-02-27 Ngm Biopharmaceuticals Inc Compositions and methods of use for treating metabolic disorders

Also Published As

Publication number Publication date
US20220009958A1 (en) 2022-01-13
CN110770251A (zh) 2020-02-07
JP2020517657A (ja) 2020-06-18
US20200131225A1 (en) 2020-04-30
EP3612558A1 (fr) 2020-02-26
WO2018193033A1 (fr) 2018-10-25

Similar Documents

Publication Publication Date Title
MA50746A (fr) Protéines de fusion comprenant des enzymes d'enzymothérapie substitutive
IL281804A (en) Protein purification methods
MA46228A (fr) Inhibiteurs bicycliques fusionnés de l'interaction ménine-mll
SG11202011743SA (en) Fusion proteins comprising progranulin
MA48998A (fr) Peptide d'activation du récepteur gip
IL261040B (en) Protein purification
MA45684A (fr) Protéine d'apport du cerveau
MA50908A (fr) Formulations de protéines de fusion vegfr-fc
DK3464331T3 (da) Stabiliserede præfusions-rsv f-proteiner
MA46717A (fr) Variantes de l'endonucléase homing tcra
GB201711481D0 (en) Protein purification
MA50174A (fr) Formules de protéines de fusion vegfr-fc
GB201800334D0 (en) Modified protein
ZA202003845B (en) Fusion proteins
SG11202101904UA (en) Spd-1 variant - fc fusion proteins
IL279057A (en) Antimicrobial fusion proteins containing endolysin and their uses
ZA202102533B (en) Fusion protein
MA42497A (fr) Procédés et compositions pour la régulation sélective de l'expression protéique
MA50141A (fr) Procédés de purification de protéines de fusion d'albumine
MA41961A (fr) Procédés de régénération d'adsorbants solides
EP3649159C0 (fr) Protéine de fusion
EP3406623A4 (fr) Procédé de purification de protéine
GB201712792D0 (en) Fusion protein
MA42478A (fr) Protéines de liaison d'antigène pour la marinobufagénine
HK1251456A1 (zh) 免疫球蛋白融合蛋白及其用途